-
-
15/10/2024 16/10/2024 America/Toronto Paragraph IV Disputes Paragraph IV Disputes Master Symposium
October 15 – 16, 2024
Hyatt Regency McCormick Place, Chicago, IL
Please visit https://www.americanconference.com/paragraph-iv-disputes-master-symposium/ for more information and updates. Hyatt Regency McCormick Place, Chicago, IL true DD/MM/YYYY 1440 use-title -
-
-
15/10/2024 16/10/2024 America/Toronto Paragraph IV Disputes Paragraph IV Disputes Master Symposium
October 15 – 16, 2024
Hyatt Regency McCormick Place, Chicago, IL
Please visit https://www.americanconference.com/paragraph-iv-disputes-master-symposium/ for more information and updates. Hyatt Regency McCormick Place, Chicago, IL true DD/MM/YYYY 1440 use-title -
ACI’s Hatch-Waxman Series Advisory Board
American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.
Ryan M. Daniel
VP, Associate General Counsel, Corporate and Business Transactions
Biopharmaceuticals
Fresenius Kabi LLC
Laura DeMoor
Senior Counsel
Baxter Healthcare
Stephanie Donahue
Principal Counsel – Global Patent
Litigation, Global IP Department
Legal, Ethics & Business Integrity
Sanofi-Aventis
Serena Farquharson-Torres
Executive Director, Assistant General Counsel
Innovation Law
Bristol Myers Squibb
Linda Friedlieb
Division Counsel
AbbVie
Colin C. Heitzmann
Vice President, IP and Business Development
Daiichi Sankyo, Inc.
Jenny Johnson
Vice President, IP
Endo Pharmaceuticals
Staci Julie
SVP and Chief IP Counsel
Teva Pharmaceuticals
Neema Kumar
Vice President, IP, North America
Sandoz
James P. Leeds
Vice President and Chief Patent Counsel – Hatch Waxman Litigation
Eli Lilly & Company
Mary J. Morry
Counsel, IP Litigation
Merck Sharp & Dohme LLC
Jeffrey N. Myers, Ph.D.
Vice President & Assistant General Counsel
Pfizer Inc
Aaron Pereira
Senior Director of Patents
Ferring Pharmaceuticals
Brian Stone
Vice President
Assistant Global General Counsel Regulatory
Mylan
Lars P. Taavola
VP, Chief IP Counsel & General
Counsel, Specialty Generics
Mallinckrodt Pharmaceuticals
Andrea D. Tiglio, PhD, JD
Executive Director
Assistant General Counsel, Intellectual Property
Jazz Pharmaceuticals
Maryll W. Toufanian
Senior Vice President, Regulatory Strategy and Policy
Amneal Pharmaceuticals
Kevin Zive
Vice President, General Counsel, and Head of Global Intellectual Property
Apotex Inc.
Emeritus Members
Stephen R. Auten
Partner, Chair of Pharmaceutical & Life Sciences Litigation
Taft Stettinius & Hollister LLP
(Former Vice President, IP, Sandoz, Inc.)
Guy Donatiello
Principal
Odyssey Pharmaceuticals Consulting
(Former SVP, IP, Endo Pharmaceuticals)
George W. Johnston
Counsel
Gibbons P.C.
(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)
Honorable Kathleen M. O’Malley (Ret.)
Of Counsel
Sullivan & Cromwell LLP
Former United States Circuit Judge, U.S. Court of Appeals for the Federal Circuit
Honorable Teresa Rea
Consultant
Rea Consulting LLC
Former Acting Director of the USPTO
Shashank Upadhye
Partner
Upadhye Tang LLP
Former Vice President – Global Intellectual Property, Apotex, Inc.
